Bicycle Therapeutics (BCYC) EPS (Basic) (2018 - 2026)
Bicycle Therapeutics (BCYC) reported EPS (Basic) of -$0.87 for Q1 2026, up 1.14% on a YoY basis from -$0.86 in Q1 2025, and down 200.0% quarter-over-quarter from -$0.29 in Q4 2025.
Bicycle Therapeutics (BCYC) EPS (Basic) (2018 - 2026) Analysis & Trends
Bicycle Therapeutics has reported EPS (Basic) for 9 years, with the latest figure at -$0.87 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 1.14% year-over-year to -$0.87; the trailing twelve-month figure through Mar 2026 stood at -$3.15 (changed 0.32% YoY), and the FY2025 full-year result was -$3.16, down 8.97% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.87, down from -$0.29 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.29 in Q4 2025, with the low at -$1.41 in Q2 2023.
- Historically, EPS (Basic) has averaged -$0.93 across 5 years, with a median of -$0.9 in 2022.
- Annual changes were most pronounced in 2022 — EPS (Basic) plunged 65.57% — and 2025, when it jumped 61.33%.
- Bicycle Therapeutics' EPS (Basic) stood at -$1.01 in 2022, then fell by 11.88% to -$1.13 in 2023, then surged by 33.63% to -$0.75 in 2024, then jumped by 61.33% to -$0.29 in 2025, then sank by 200.0% to -$0.87 in 2026.
- The last three EPS (Basic) figures came in at -$0.87 (Q1 2026), -$0.29 (Q4 2025), and -$0.85 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Bicycle Therapeutics | 278.04 Mn | 278.04 Mn | - | -0.87 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.87 |
| Dec 31, 2025 | -0.29 |
| Sep 30, 2025 | -0.85 |
| Jun 30, 2025 | -1.14 |
| Mar 31, 2025 | -0.88 |
| Dec 31, 2024 | -0.75 |
| Sep 30, 2024 | -0.74 |
| Jun 30, 2024 | -0.77 |
| Mar 31, 2024 | -0.62 |
| Dec 31, 2023 | -1.13 |
| Sep 30, 2023 | -1.26 |
| Jun 30, 2023 | -1.41 |
| Mar 31, 2023 | -1.30 |
| Dec 31, 2022 | -1.01 |
| Sep 30, 2022 | -0.96 |
| Jun 30, 2022 | -0.90 |
| Mar 31, 2022 | -0.93 |
| Dec 31, 2021 | -0.61 |
| Sep 30, 2021 | -0.59 |
| Jun 30, 2021 | -0.74 |